Abstract Diruthenium tetracarbonyl complexes of the type [Ru 2 (CO) 4 (l 2 -g 2 -O 2 CR) 2 L 2 ] containing a Ru-Ru backbone with four equatorial carbonyl ligands, two carboxylato bridges, and two axial two-electron ligands in a sawhorse-like geometry have been synthesized with porphyrin-derived substituents in the axial ligands The compounds demonstrated no cytotoxicity in the absence of laser irradiation but exhibited good phototoxicities in HeLa and A2780 cells when exposed to laser light at 652 nm, displaying an LD 50 between 1.5 and 6.5 J/cm 2 in these two cell lines and more than 15 J/cm 2 for the others. Thus, these types of porphyric compound present specificity for cancer cell lines of the female reproductive system and not for normal cells; thus being promising new organometallic photosensitizers.
Introduction
Photodynamic therapy is a modality of treatment already used in the clinic for cancer treatment [1] [2] [3] [4] . It involves a nontoxic photoactivable dye called a ''photosensitizer'' in combination with harmless visible light of a specific wavelength to excite the photosensitizer. The photosensitizer reaches a high-energy triplet state which reacts with cellular oxygen to form toxic reactive oxygen species such as singlet oxygen and oxygen radicals which will oxidize cellular nuclei, fatty, and amino acids. The photosensitizers commonly bear a tetrapyrrolic ring such as porphyrins, chlorins, or bacteriochlorins and have been shown to concentrate in cancer cells [3, 5, 6] . On the other hand, organometallic drugs, especially platinum derivatives, are commonly used in cancer therapy [7] [8] [9] . However, significant problems associated with platinum compounds limit their applicability, including a high general toxicity and drug resistance by several types of cancer [10, 11] . Some progress has been made to overcome these limitations with other organometallics such as ruthenium-based agents [12] . Ruthenium is an attractive alternative to platinum since ruthenium compounds are known to display less general toxicity than their platinum counterparts, but are also able to interact with DNA and proteins [13] . Moreover, ruthenium derivatives are believed to be taken up by cells via the transferrin receptor system in particular and present some selectivity for cancer cell lines [12] .
Combining both an organometallic group with a porphyric photosensitizing moiety could therefore represent a promising approach. Complexes of porphyrins coordinated to platinum groups were developed mainly by Lottner et al. a few years ago and show some promise [14] [15] [16] [17] [18] . More recently, we have coordinated arene-ruthenium(II) moieties to pyridylporphyrins and such complexes showed good cytotoxicities and phototoxicities toward human melanoma cancer cells [19, 20] . In this study, we have chosen the diruthenium tetracarbonyl structure as the organometallic agent and backbone of the complexes. These sawhorse-type diruthenium complexes have been known since 1969, when J. Lewis and co-workers [21] reported the formation of [Ru 2 (CO) 4 (l 2 -g 2 -O 2 CR) 2 ] n polymers by refluxing [Ru 3 (CO) 12 ] in the corresponding carboxylic acid (HO 2 CR), and the depolymerization of these materials in coordinating solvents to give dinuclear complexes of the type [Ru 2 (CO) 4 (l 2 -g 2 -O 2 CR) 2 L 2 ], L being acetonitrile, pyridine, or other two-electron donor ligands (Structure 1).
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Herein, we describe the synthesis, the spectroscopic characterization, the electrochemical behavior, and the biological activity in human normal fibroblastic cells and in many types of human cancer cells of diruthenium tetracarbonyl complexes of the type [Ru 2 (CO) 4 
Experimental

Materials and methods
All manipulations were carried out by conventional Schlenk techniques under a nitrogen atmosphere. Organic solvents were dried, degassed, and saturated with nitrogen prior to use. All reagents were purchased from Aldrich, Fluka, and Porphyrin Systems and used as received. Dodecacarbonyltriruthenium [22] and 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (pta) [23] were prepared according to published methods. NMR spectra were recorded at 25°C using a Bruker 400 MHz spectrometer. IR spectra were recorded using a PerkinElmer 1720X Fourier transform IR spectrometer (4,000-400 cm -1 ). UV-vis absorption spectra were recorded with a Uvikon 930 spectrophotometer. Microanalyses were performed by the Laboratory of Pharmaceutical Chemistry, University of Geneva (Switzerland). Electrospray mass spectra studies were realized using an APEX II Fourier transform ion cyclotron resonance mass spectrometer equipped with a 9.4-T superconducting magnet (Bruker Daltonics). Electrochemical measurements were carried out with a computer-controlled lAUTOLAB III multipurpose polarograph (Eco Chemie, The Netherlands) at room temperature using a Metroohm three-electrode cell with a rotating platinum disc electrode (AUTOLAB RDE; 3-mm diameter) as the working electrode, a platinum sheet auxiliary electrode, and an Ag/AgCl reference electrode (3 M KCl). The compounds analyzed were dissolved in dichloromethane (Fluka, absolute; declared H 2 O content 0.005% or less) to give a solution containing 5 9 10 -4 M of the analyte and 0.1 M Bu 4 NPF 6 (Fluka, purissimum for electrochemistry). In the case of poorly soluble compounds, saturated solutions were used. The solutions were degassed and saturated with argon prior to the measurement and then kept under an argon blanket. The redox potentials are given relative to an internal ferrocene/ferrocenium reference. Quantum yields were assessed after excitation at 414 nm as previously described [20] . Fluorescence quantum yields at 648 nm were determined using a PerkinElmer LS50 spectrofluorometer. The singlet oxygen quantum yield was determined using the singlet oxygen specific fluorescence at 1,270 nm monitored by a liquid-nitrogen-cooled germanium detector (model EO-817L, North Coast Scientific) from the DCPR facility, ENSIC, Nancy, France. Evaluation of uptake and toxicity of the complexes Cells in 48-well plates (Costar) were exposed at 37°C to increasing concentrations of complexes in complete culture medium for 48 h. After they had been washed with phosphate-buffered saline (PBS), the supernatants were replaced with fresh medium and the cell-associated content was evaluated by its porphyrin characteristic fluorescence in a thermostated fluorescence microplate reader (Cytofluor, PerSeptive BioSystems), with excitation and emission filters set at 409 ± 5 and 645 ± 10 nm, respectively, essentially as previously described [25, 26] . Cell survival was measured using the 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide (MTT) test. MTT (Merck) was added at 250 lg/mL and incubation was continued for 2 h, as previously described [19] . Then the cell culture supernatants were removed, the cell layer was dissolved in i-PrOH/0.04 N HCl, and the absorbance at 540 nm was measured in a 96-well multiwell-plate reader (iEMS Reader MF, Labsystems, Bioconcept, Switzerland) and compared with the values of control cells incubated without complexes. Experiments were conducted in triplicate wells and repeated at least twice.
Fluorescence microscopy Cells were grown on histological slides in complete medium and exposed to the complexes overnight at 25 lM concentrations. Slides were washed and incubated with the nuclear stain 4 0 ,6 0 -diamidino-2-phenylindolyl hydrochloride (DAPI; Roche Diagnostics, Mannheim, Germany, 1 lg/mL in PBS) for 10 min at 37°C, and examined in PBS under a fluorescence microscope (Axioplan2, Carl Zeiss, Feldbach, Switzerland) and filters were set at 365-nm excitation light (BP 365/12, FT 395, LP 397) for DAPI and 535-nm excitation light (BP 510-560, FT 580, LP 590) for porphyrins as previously described [19, 20, 25] .
Photodynamic therapy
Cells in 96-well plates (Costar) were incubated in the dark in complete medium with 2.5 lM complexes for 24 h. Culture medium was replaced by medium without phenol red (Gibco) containing 5% fetal calf serum. Cells were irradiated with a laser at 652 nm (Ceralas 652 laser diode, Biolitec, Jena, Germany) coupled to with a frontal diffuser (Medlight, Ecublens, Switzerland), at an irradiance of 30 mW/cm 2 and with light doses ranging from 2.5 to 20 J/ cm 2 as previously described [19, 20, 24, 25] . Cell survival was assessed with the MTT assay 24 h after the end of the irradiation and compared with values for cells irradiated without the complexes as previously described [19] . The LD 50 (light dose necessary to induce 50% inhibition of cell growth) values were determined after linearization using the medium effect algorithm as described elsewhere [27] .
Results
Syntheses and characterization
The thermal reaction of [Ru 3 (CO) 12 ] with an excess of the corresponding carboxylic acid HO 2 CR (R is CH 3 (Fig. 1) . Complexes 1-4 were isolated by precipitation and characterized by IR, NMR, and ESI-MS as well as by elemental analysis.
All compounds exhibit in the m (CO) region of the IR spectrum the characteristic three-band pattern of the Ru 2 (CO) 4 sawhorse unit, observed in all complexes of this type [21, 28] . Similarly, for the two carboxylato bridges only one m (OCO) absorption is observed, in accordance with the spectra of other [Ru 2 (CO) 4 [21, 28] .
Whatever the position of the porphyrin at the sawhorse unit is, as axial ligands or as carboxylato bridges, the chemical shift of the signal corresponding to the NH protons in the 1 H NMR spectra remains unchanged (d = -2.75 ppm for 1 and 2, -2.74 ppm for 3, and -2.78 ppm for 4). In the 13 C { 1 H} NMR spectra, the peaks of the terminal carbonyl groups and of the carboxylato bridges are found around 180 and 205 ppm, respectively, again in agreement with those reported in the literature [29] .
The electronic spectra of porphyrin complexes 1-3 exhibit the typical four Q bands between 510 and 650 nm and the intense Soret band around 420 nm ( Table 1 ). The absorption bands of the uncoordinated porphyrin units remain unchanged upon coordination to the dinuclear sawhorse-type moiety, thus suggesting that there is no perturbation of the porphyrin p-orbitals upon coordination.
The redox behavior of complexes 1, 2 and 4 was studied by cyclic voltammetry at a platinum disc electrode. The pertinent data are summarized in Table 2 . The redox behavior of 1 can be regarded as a superposition of the redox response of the molecular parts: the diruthenium core gives rise to an irreversible oxidation wave, while the porphyrin pendants undergo an oxidation and a two consecutive reduction process. The assignment of the most positive oxidation peak was not possible from the data available. The redox changes attributable to the porphyrin moiety are reversible at scan rates of 0.1-1.0 V/s and occur independently at both porphyrin pendants (i.e., as a sum of two identical one-electron waves), which rules out any significant electronic coupling between the porphyrin moieties. The second reduction is probably one-electron reduction as well but occurs at the onset of the base electrolyte decomposition. It is worth noting that the B-D-E waves (Table 2) are observed in a similar pattern and at roughly similar potentials as for free 5-(4-pyridyl)-10,15,20-triphenyl-21,23H-porphyrin [30] . This indicates that coordination via the peripheral pyridine moiety has only a minor influence (e.g., inductive) on the redox properties of the porphyrin framework. Complex 2 shows two oxidations possibly attributable to the diruthenium core (A and B) followed by two reversible oxidations localized most likely at the porphyrin units (C and D). The subsequent oxidation (wave H) occurs already at the onset of base electrolyted decomposition (Fig. 2) . The first oxidation (A) is observed with full reversibility down to 0.1-V/s scan rate when scanned separately. Increasing the switching potential beyond the second (B, irreversible) and third (C, reversible) oxidations makes the first oxidative wave quasi-reversible (the peak current ratio i pa /i pc increases with the scan rate) and fully irreversible (up to 5 V/s), respectively. The redox properties of 4 correspond to the sum of those of 1 and 2. Therefore, because of the similar redox behavior of the individual parts, the individual redox waves overlap, forming broad redox waves that do not allow any detailed analysis.
Biological assays
The effect of the organometallic porphyrin complexes 1-3 was investigated in vitro in human normal fibroblastic cells and in several human cancer cells: HeLa cervix, A2780 and Ovcar ovarian, A549 pulmonary, Me300 melanoma, PC3 and LnCap prostate, KB head and neck, MCF7 and MDA-MB231 breast, as well as HT29 colon cancer cells. The poor solubility of 4 did not allow its assessment. Cells were exposed for 48 h to increasing concentrations of compounds 1-3 and their survival was determined using the MTT cell survival assay. Representative results in human normal fibroblastic cells and A549, HeLa, and A2780 cancer cells are shown in Fig. 3 (not shown for the other cells). In the absence of laser exposure (dark toxicity), compounds 1-3 did not display any cytotoxic effect in all the cell types up to 100 lM concentration.
The uptake of compounds 1-3 was also studied by quantification of the characteristic fluorescence of porphyrin derivatives (k exc /k em = 410 nm/650 nm) in cells exposed to the complexes at concentrations from 5 to 100 lM. The results revealed that HeLa and A2780 cells presented a good uptake profile, whereas other normal and cancer cells presented a very low uptake of the compounds (Fig. 3) . These results were checked by fluorescence microscopy; the fluorescence associated with porphyrin appears red, whereas cell nuclei appear blue with DAPI counterstaining (Fig. 4) . For these compounds in all cell lines, nuclear fragmentation was not observed, suggesting the absence of cell apoptosis, at least for this time course. Good accumulation of porphyrins in the cytoplasm of HeLa, A2780, and Ovcar (not shown) cells was observed but was not found in other cell types (only human normal fibroblastic cells and A549 pulmonary cell line being shown).
The phototoxic efficacy of the porphyrin complexes was assessed at 2.5 lM concentration. Cells were incubated for 24 h with compounds 1-3 before irradiation at 652 nm (30 mW/cm 2 ) and light doses from 2.5 to 20 J/cm 2 . MTT cell survival test was performed after a further incubation The potentials are quoted relative to a ferrocene/ferrocenium reference. Peak potentials are given for irreversible (ir) processes: anodic peak potential (E pa ) for oxidations, cathodic peak potential (E pc ) for reductions. The potential for reversible (r) couples is defined as the mean of the anodic and cathodic peak potentials:
e E°0 is given, f additional wave: G -1.56 (ir), g E pa is given Table 3 . The complexes were efficient in HeLa and A2780 cells with 1.5 \ LD 50 \ 6.5 J/cm 2 , whereas, phototoxicities in other cell types were very low with LD 50 values of more than 15 J/cm 2 . In all cancer cell lines, complex 1 appeared to be slightly more efficient. Thus, the phototoxicity results are coherent with uptake results which showed that the compounds were only taken up by HeLa and A2780 cell lines.
Thus, these types of compound present a selectivity pattern toward female reproductive cancer cells compared with other types of cancer cells but also compared with human normal primary fibroblasts.
Discussion
In the present study, our aim was to develop molecules able to combine the photosensitizing properties of porphyrins with the organometallic effects of diruthenium carboxylate as potential drug candidates for cancer therapy as we have already reported for arene-ruthenium(II) moieties coordinated to pyridylporphyrin derivatives [19, 20] . The cytotoxicities of the complexes were tested in human normal fibroblasts and in several human cancer cell lines. Our new organometallic-porphyrin complexes displayed no cytotoxicities in the dark for concentrations up to 100 lM for all the cell lines tested. This is in accordance with non-porphyrin-containing diruthenium tetracarbonyl sawhorse-type complexes which show no cytotoxicity on the A2780 ovary carcinoma cell line [31] and with other diruthenium carboxylate derivatives which presented some IC 50 values greater than120 lM in the HeLa cell line [32] .
Interestingly, uptake studies revealed that our complexes are only taken up by human HeLa cervix and A2780 ovary carcinoma cell lines and not by the other human normal or cancer cell lines. These data were established using the characteristic fluorescence of porphyrin derivatives. Fluorescence microscopy studies also demonstrated , and 3 (c) in human cell lines. Cells were exposed to compounds (2.5 lM) in the dark for 24 h before being exposed to increasing doses of light at 652 nm. Then the amount of metabolically active cells was determined 24 h later by the MTT assay. Cells not exposed to the compounds, but irradiated, were used as controls. A549 (squares), HeLa (triangles), A2780 (circles), and normal fibroblasts (crosses) Cells were exposed to the complexes (2.5 lM) for 24 h in the dark, and were then illuminated with a red laser (k = 652 nm). The 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide cell survival test was performed 24 h after the irradiation. The LD 50 values (light dose necessary to inhibit 50% cell survival) were determined using the medium effect algorithm [27] that the complexes are taken up by HeLa, Ovcar, and A2780 cells and concentrate in the cell cytoplasm and organelles, but not in the nucleus, as did our previously reported compounds [19, 20] but this contrasts with some ruthenium-based drugs known to accumulate in the nucleus [33, 34] . Photodynamic studies provided coherent results compared with uptake studies since our complexes induce phototoxicities in HeLa cervix and A2780 ovary carcinoma cell lines and not in other cancer and normal fibroblast cells. Moreover, our complexes appeared to be efficient since they are active at low concentration (2.5 lM) and at low light dose (1.5 \ LD 50 \ 6.5 J/cm 2 ). In both cell lines, complex 1 was found to be slightly more active than complexes 2 and 3. The reasons for this cell specificity remain unknown but must be attributed to the diruthenium structure since the porphyrin alone does not have such specificity properties. Other organometallic compounds conjugated to hydrophobic heterocycles have already been demonstrated to present a specificity to breast estrogen receptors [35, 36] . Although, this is not the case for our compounds since both MCF7 (estrogen-receptor positive) and MDA-MB231 (estrogen-receptor negative) breast cancer cell lines were unable to take up our compounds, we hypothesize the targeting of another specific receptor of female reproductive cancer cells since only cervix and ovarian cancers are able to take up the complexes. The reasons for this specificity are currently under investigation, but at the moment it remains unclear why the complexes are so selective. However, these new compounds are efficient photosensitizers and could provide new hints for the design of organometallodrugs specific for cancers of the female reproductive system that do not target normal cells.
